Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Condition:   Immunologic Deficiency SyndromesIntervention:   Biological: GC5107Sponsors:   Green Cross Corporation;   ParexelNot yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2016 Category: Research Source Type: clinical trials